Cargando...
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients
Aims: To measure pimecrolimus blood concentrations and to evaluate tolerability and efficacy in children and infants treated topically for atopic dermatitis with pimecrolimus cream 1% for three weeks. Methods: Three open label, non-controlled, multiple topical dose studies were conducted in children...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2003
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1719352/ https://ncbi.nlm.nih.gov/pubmed/14612358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.88.11.969 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|